Meeting
2011 ASCO Annual Meeting
TLI-ATG for nonmyeloablative stem cell transplant: A single center experience.
Authors
D. A. Wong
Cedars-Sinai Medical Center, Los Angeles, CA
D. A. Wong , A. S. Steinberg , C. Bresee , A. M. Lopez , S. Lim , M. Lill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Allogeneic Bone Marrow
Citation
J Clin Oncol 29: 2011 (suppl; abstr 6578)
Abstract #
6578
Poster Bd #
35G
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Allogeneic stem cell transplantation for patients over age 65 with acute myelogenous leukemia and myelodysplastic syndrome.
First Author: Henry Jacob Conter
Poster
2020 ASCO Virtual Scientific Program
Grade III-IV cytokine release syndrome is associated with inferior survival in patients undergoing haploidentical donor stem cell transplants.
First Author: Omar Albanyan
Poster
2016 ASCO Annual Meeting
Long-term outcomes of non-myeloablative allogeneic stem cell transplantation (alloSCT) in patients with relapsed mantle cell lymphoma (MCL).
First Author: Issa F. Khouri
Poster
2013 ASCO Annual Meeting
Incidence of posttransplantation lymphoproliferative disorder (PTLD) following allogeneic blood or marrow transplantation (alloBMT) using post-transplantation cyclophosphamide (PT-Cy) for graft-versus-host disease (GVHD) prophylaxis.
First Author: Jennifer Ann Kanakry